课题基金 / 基金详情

MONITORING CMV VIRAL LOADS

MONITORING CMV VIRAL LOADS
监测 CMV 病毒载量
批准号:
6122145
负责人:
MARK A BEILKE
金额:
$1.12万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-19 至 1999-11-30

项目摘要

项目成果

MARK A BEILKE的其他基金

相似基金

相关文献

中文摘要
翻译
本研究的目的是测量正在筛查CMV视网膜炎或已被诊断为CMV视网膜炎并正在接受治疗的HIV感染者血液中的巨细胞病毒(CMV)水平。本研究旨在确定三种不同的病毒学检测方法在预测CD 4计数低于100/mm 3的艾滋病患者发生CMV视网膜炎中的敏感性和特异性。 其次,将在预测接受CMV视网膜炎治疗的受试者中治疗失败的灵敏度和特异性方面比较相同的三种测定。将使用三种不同的实验室检查对无症状受试者进行为期12个月的随访,在基线时进行检查,然后每三个月进行一次。 将在基线时对治疗受试者进行随访,然后在CMV视网膜炎的诱导和维持治疗期间进行随访,直至临床诊断为治疗失败。
英文摘要
The purpose of this study is to measure the levels of cytomegalovirus (CMV) in the blood of persons with HIV who are being screened for CMV retinitis, or who have been diagnosed with and are receiving treatment for CMV retinitis. This study is to determine the sensitivity and specificity of three different virological assays in predicting the development of CMV retinitis in AIDS patients with CD4 counts below 100/mm3. Secondly, the same three assays will be compared in terms of sensitivity and specificity in predicting treatment failures in subjects undergoing treatment for CMV retinitis. Asymptomatic subjects will be followed, using three different laboratory tests, for twelve months, with tests being performed at baseline and then every three months thereafter. Treated subjects will be followed at baseline, and then during induction and maintenance therapy for CMV retinitis until treatment failure is diagnosed clinically.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunomodulatory Function of Human T Cell Leukemia Virus Type 2 (HTLV-2)
Immunomodulatory Function of Human T Cell Leukemia Virus Type 2 (HTLV-2)
Immunomodulatory Function of Human T Cell Leukemia Virus Type 2 (HTLV-2)
HIV, HTLV AND DRUG ABUSE
  • 批准号:
    7716239
  • 项目类别:
  • 资助金额:
    $6.33万
  • 财政年份:
    2008
  • 负责人:
    MARK A BEILKE
  • 依托单位:
海外基金